Quantitative Systematic Strategies LLC Sarepta Therapeutics, Inc. Transaction History

Quantitative Systematic Strategies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 07, 2019	SELL	$72.81 - $156.91 $197,460 - $425,539	-2,712 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$112.21 - $151.95 $304,313 - $412,088	2,712 New	2,712 $412,000
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $302,957 - $463,089	-3,113 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $78,641 - $110,149	682 Added 28.05%	3,113 $503,000
Q2 2018 Aug 07, 2018	SELL	$71.74 - $153.69 $78,770 - $168,751	-1,098 Reduced 31.11%	2,431 $321,000
Q1 2018 May 04, 2018	BUY	$54.02 - $82.27 $190,636 - $290,330	3,529 New	3,529 $261,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.